General practitioner perceptions of extended pharmacy services and modes of collaboration with pharmacists

Journal of Pharmacy Practice and Research

Volumn 37, Issue 3, 2007, Pages 182-186

  Van, Connie ^a   Krass, Ines ^a   Mitchell, Bernadette ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CITY; FEMALE; GENERAL PRACTITIONER; HEALTH SERVICE; HUMAN; IMMUNIZATION; MALE; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT MONITORING; PERCEPTION; PHARMACIST; PHARMACY; PHYSICIAN ATTITUDE; PRIVATE PRACTICE; PROFESSIONAL PRACTICE; QUALITATIVE ANALYSIS; RURAL AREA; SCREENING; SEMI STRUCTURED INTERVIEW; SUBURBAN AREA;

EID: 35348993179     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00739.x     Document Type: Article

References (26)

1. Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother 2005; 39: 1911-17.
2. Ferro LA, Marcrom RE, Garrelts L, Bennett MS, Boyd EE, Eddinger L, et al. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc 1998; 38: 655-64.
3. Bogden PE, Koontz LM, Williamson P, Abbott RD. The physician and pharmacist team: an effective approach to cholesterol reduction. J Gen Int Med 1997; 12: 158-64.
4. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Int Med 1998; 13: 740-5.
5. Borenstein JE, Graber Q Saltiel E, Wallace J, Ryu S, Archi J, et al. Physician-pharmacist co-management of hypertension: a randomized, comparative trial. Pharmacotherapy 2003; 23: 209-16.
6. Carter BL. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH. J Manage Care Pharm 2004; 10: S18-S25.
7. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring Study. Arch Intern Med 1999; 159: 1939-45.
8. Landers M, Blenkinsopp A, Pollock K, Grime J. Community pharmacists and depression: the pharmacist as intermediary between patient and physician. Int J Pharm Pract 2002; 10: 253-65.
9. McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. J Am Pharm Assoc 2003; 43: 511-18.
10. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005; 27: 1104-11.
11. Roberts MS, Stokes JA. Prescriptions, practitioners and pharmacists. Med J Aust 1998; 168: 317-18.
12. Reebye RN, Avery AJ, Van den Bosch WJ, Aslam M, Nijholt A, Van der Bij A. Exploring community pharmacists' perceptions of their professional relationships with physicians, in Canada and the Netherlands. Int J Pharm Pract 1999; 7: 149-58.
13. Australian Government Department of Health and Ageing. GP HMR fact sheet and process chart. Available from 〈www.health.gov.au/internet/wcms/ publishing.nsf/Content/health-epc-dmmr.htm〉. Accessed 1 November 2006.
14. Zillich AJ, Doucette WR, Carter BL, Kreiter CD. Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health 2005; 8: 59-66.
15. McDonough RP, Doucette WR. Building working relationships with providers. J Am Pharm Assoc 2003; 43: S44-S45.
16. Krass I, Taylor S, McInman A, Armour C. An integrated model for disease state management (DSM) in diabetes: collaboration of the community pharmacist and GP in continuity of care. J Pharm Technol 2006; 22: 3-8.
17. Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002; 162: 1149-55.
18. McLachlan A, Spindler M, Fois R, Krass I, Chen T, Bajorek BV A community pharmacy based anticoagulant management service. Available from 〈beta.guild.org.au/research/project_display.asp?id=255〉. Accessed 1 May 2006.
19. Chiquette E, Amato MG Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641-7.
20. Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother 2002; 36: 585-91.
21. Chen T, Penrose-Wall J, Bell S, McLachlan A, Aslani P, Whitehead P. Case conferences and care planning. Collaboration between community pharmacists and general practitioners. Available from 〈beta.guild.org.au/research/ project_display.asp?id=240〉. Accessed 1 May 2006.
22. Amruso NA, O'Neal ML. Pharmacist and physician collaboration in the patient's home. Ann Pharmacother 2004; 38: 1048-52.
23. Berbatis CG, Sunderland VB, Mills CR, Bulsara M. National pharmacy database project 2003. Available from 〈beta.guild.org.au/research/ project_display.asp?id=239〉. Accessed 15 March 2007.
24. Urbis Keys Young. Evaluation of HMR program. Available from 〈beta.guild.org.au/research/project_display.asp?id=277〉. Accessed 15 March 2007.
25. Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: pharmacists' participation and impact. J Am Pharm Assoc 2003; 43: 470-82.
26. Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004; 38: 764-70.